thomas.schmitt.m
About Candidate
Creative Diagnostics‘ integrated approach to target identification and validation harnesses the vast potential of large data sets, computational tools and therapeutic expertise to generate breakthrough hypotheses that drive the drug discovery process. By combining multiple viral vector technologies, including adenovirus, and sophisticated cellular assays, Creative Diagnostics provides validated new drug targets in the antiviral and anti-infective space. In addition, the company offers CRISPR or siRNA technologies to help clients identify and validate targets of interest by verifying target functional pathways, proliferation, gene expression analysis and protein modification.
